Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Healthcare

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced delivery of certain active molecules into brain tissue. The Company has also developed DehydraTECH formulations for other applications demonstrating bio-absorption when administered intraorally and topically. It operates through two segments: Intellectual Property and Products. It also operates a licensed in-house research laboratory and holds an intellectual property portfolio with 35 patents granted and many patents pending worldwide. Its subsidiaries include Lexaria CanPharm ULC, and Lexaria CanPharm Holdings Corp.

NDAQ:LEXX - Post by User

Lexaria Bioscience Corp > RS

<< Previous

Bullboard Posts

Next >>

Post by winnerscircleon Jan 10, 2021 4:38pm

268 Views

Post# 32263984

RS

After the RS well have about 3mill total shares.....damm.any sort of excitement this can run hard and heavy...and with that low float were for sure raising some capital......we should open up Tuesday on the nasdaq around 7.50 and with such a low float (even after raising some money) we can run up to 50-75usd in 2021.....GL

<< Previous

Bullboard Posts

Next >>

BMO launches enhanced platform with tools for options trading